To describe therapeutic effect of oral and topical carbonic anhydraseinhibitor (CAI) for bilateral cystoid macularedema (CME) in a patient with retinitis pigmentosa(RP)
Setting/Venue
Department of ophthalmology,HabibBourguiba university hospital, Faculty of medicine, University of Sfax,Tunisia
Methods
A 31-year-old woman suffering from RP presented with bilateral blurred vision.Complete ophthalmologic examination and spectraloptical coherence tomography (OCT) were performed.
Results
Ocular examination revealed a best corrected visual acuity of 10/10 on the right eye and 7/10 on the left eye. There were no pathological findings in the anterior segments. Fundus examination showed a pale optic disc, narrowed arterioles and bone spicule pigmentary changes on the periphery in both eyes.Subsequentdomain optical coherence tomography (OCT) revealed bilateralCME. Oral acetazolamide was conducted for 17 months. It resulted in regression of CME shown through OCT examinations. However, as the patient reported paresthesias of the extremities, the treatment was switched to topical dorzolamidechlorhydrate.There was a continuousimprovement in patient’s condition with a total CME disappearance on the right eye and persisting a cyst on the left eye.
Conlusions
RP is a heterogeneous group of inherited retinal dystrophies inwhichvisual loss occurs from degeneration of photoreceptors and the presence of complications such as CME, epiretinal membrane, and cataract. CME is associated with RP in 10-50%of cases. There are currently no approved guidelines for its management. Consenquently, various therapeutic options have been considered including topical and oral CAI, intravitreal steroids and anti-vascular endothelial growth factor agents, grid laser photocoagulation and vitrectomy. A recent systematic review recommends oral acetazolamide as first line treatment and for patients intolerant to its side effects topical dorzolamidecan be a good alternative. Dorzolamide may also be considered as first line treatment for pediatric and elderly patients.